Chris Storgard, MD
Fate Therapeutics · Ardea Biosciences, Inc. · Biogen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chris Storgard, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:49 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02354443 · A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic DisordersFate Therapeutics · terminated · Metabolic Disorders · study director
- Ph1NCT02354417 · A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesFate Therapeutics · terminated · Hematologic Malignancies · study director
- Ph3NCT01650246 · Open-Label Lesinurad Monotherapy Extension Study in GoutArdea Biosciences, Inc. · completed · Gout · study director
- Ph3NCT01510769 · Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and FebuxostatArdea Biosciences, Inc. · completed · Tophaceous Gout · study director
- Ph3NCT01510158 · Combining Lesinurad With Allopurinol in Inadequate RespondersArdea Biosciences, Inc. · completed · Gout · study director
- Ph3NCT01508702 · Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase InhibitorsArdea Biosciences, Inc. · completed · Gout · study director
- Ph3NCT01493531 · Combining Lesinurad With Allopurinol in Inadequate RespondersArdea Biosciences, Inc. · completed · Gout · study director
- Ph1NCT00344786 · Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLLBiogen · terminated · B-Cell Chronic Lymphocytic Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.